Jenburkt Pharmaceuticals Ltd — Important, 07-01-2026: Company Update

Jenburkt Pharmaceuticals has submitted a compliance certificate regarding the dematerialization of shares for the quarter ended December 31, 2025. The company's Registrar and Transfer Agent confirmed that all securities received for dematerialization during the period were processed correctly, accepted or rejected as appropriate, and subsequently listed on the stock exchange. It also verified that physical share certificates received for dematerialization were properly mutilated and cancelled, and depositories were registered as owners in the member's register within 15 days. This ensures accurate record-keeping for electronic shares and market integrity, which is important for shareholders.